Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shekeeb Mohammad

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 13, 2025
Characterizing circulating biomarkers for childhood dementia disorders: A scoping review of clinical trialsArlene D'Silva, James Barnes, Jason Djafar, et al.
Clinical & Translational Immunology|February 23, 2026
Gut metabolites identified in cerebrospinal fluid of genetic interferonopathy support gut-brain endothelial dysfunctionRussell C Dale, Madysen Elbourne, Markus J Hofer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2018
Beta-propeller-associated neurodegeneration can present with dominant or isolated parkinsonismHugo Morales-Briceño, Beatriz E Sanchez-Hernandez, Esther Meyer, et al.
Clinical & Translational Immunology|June 30, 2026
Early brain-penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1-related Aicardi-Goutières syndromeRussell C Dale, Jessica Hayes, Velda X Han, et al.
Archives of Disease in Childhood|January 20, 2025
'Fighting every day': exploring caregiver quality of life and perspectives on healthcare services for children with dementia - a cross-sectional, mixed-methods studyJason Djafar, Suzanne Nevin, Nicholas Smith, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 7, 2024
'High hopes for treatment': Australian stakeholder perspectives of the clinical translation of advanced neurotherapeutics for rare neurological diseasesChristina Q Nguyen, Didu S T Kariyawasam, Tsz Shun Jason Ngai, et al.
Ebiomedicine|May 20, 2024
Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndromeErica Tsang, Velda X Han, Chloe Flutter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 17, 2017
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelinationSudarshini Ramanathan, Shekeeb Mohammad, Esther Tantsis, et al.
Clinical & Translational Immunology|January 11, 2021
Pro-inflammatory dopamine-2 receptor-specific T cells in paediatric movement and psychiatric disordersDeepti Pilli, Alicia Zou, Ruebena Dawes, et al.
Annals of Clinical and Translational Neurology|June 21, 2023
CSF neopterin and quinolinic acid are biomarkers of neuroinflammation and neurotoxicity in FIRES and other infection-triggered encephalopathy syndromesRussell C Dale, Terrence Thomas, Shrujna Patel, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 13, 2025
Characterizing circulating biomarkers for childhood dementia disorders: A scoping review of clinical trialsArlene D'Silva, James Barnes, Jason Djafar, et al.
Clinical & Translational Immunology|February 23, 2026
Gut metabolites identified in cerebrospinal fluid of genetic interferonopathy support gut-brain endothelial dysfunctionRussell C Dale, Madysen Elbourne, Markus J Hofer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2018
Beta-propeller-associated neurodegeneration can present with dominant or isolated parkinsonismHugo Morales-Briceño, Beatriz E Sanchez-Hernandez, Esther Meyer, et al.
Clinical & Translational Immunology|June 30, 2026
Early brain-penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1-related Aicardi-Goutières syndromeRussell C Dale, Jessica Hayes, Velda X Han, et al.
Archives of Disease in Childhood|January 20, 2025
'Fighting every day': exploring caregiver quality of life and perspectives on healthcare services for children with dementia - a cross-sectional, mixed-methods studyJason Djafar, Suzanne Nevin, Nicholas Smith, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 7, 2024
'High hopes for treatment': Australian stakeholder perspectives of the clinical translation of advanced neurotherapeutics for rare neurological diseasesChristina Q Nguyen, Didu S T Kariyawasam, Tsz Shun Jason Ngai, et al.
Ebiomedicine|May 20, 2024
Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndromeErica Tsang, Velda X Han, Chloe Flutter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 17, 2017
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelinationSudarshini Ramanathan, Shekeeb Mohammad, Esther Tantsis, et al.
Clinical & Translational Immunology|January 11, 2021
Pro-inflammatory dopamine-2 receptor-specific T cells in paediatric movement and psychiatric disordersDeepti Pilli, Alicia Zou, Ruebena Dawes, et al.
Annals of Clinical and Translational Neurology|June 21, 2023
CSF neopterin and quinolinic acid are biomarkers of neuroinflammation and neurotoxicity in FIRES and other infection-triggered encephalopathy syndromesRussell C Dale, Terrence Thomas, Shrujna Patel, et al.
Pageof 3